Sean Khozin

5.3k total citations
69 papers, 3.6k citations indexed

About

Sean Khozin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sean Khozin has authored 69 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 34 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Sean Khozin's work include Lung Cancer Treatments and Mutations (28 papers), Cancer Genomics and Diagnostics (16 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Sean Khozin is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Cancer Genomics and Diagnostics (16 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Sean Khozin collaborates with scholars based in United States, Belgium and Thailand. Sean Khozin's co-authors include Richard Pazdur, Gideon M. Blumenthal, Andrea Coravos, Kenneth D. Mandl, Patricia Keegan, Lijun Zhang, Shenghui Tang, Jennifer MacGregor, Glenn Merlino and Binwu Tang and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Sean Khozin

68 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sean Khozin United States 27 1.6k 1.2k 959 589 353 69 3.6k
Paul G. Kluetz United States 34 1.8k 1.1× 1.3k 1.1× 579 0.6× 608 1.0× 671 1.9× 174 4.0k
Barnett S. Kramer United States 31 1.4k 0.9× 1.7k 1.5× 763 0.8× 546 0.9× 430 1.2× 82 4.4k
Yingye Zheng United States 36 1.2k 0.7× 904 0.8× 1.0k 1.1× 571 1.0× 217 0.6× 128 4.5k
Lisa Wang Canada 42 1.8k 1.1× 1.2k 1.0× 1.7k 1.8× 647 1.1× 186 0.5× 191 5.1k
Roman Gulati United States 34 1.6k 1.0× 2.3k 2.0× 672 0.7× 662 1.1× 236 0.7× 128 3.6k
Mourad Tighiouart United States 38 1.7k 1.1× 930 0.8× 1.6k 1.7× 700 1.2× 229 0.6× 152 5.0k
Gilberto Lopes United States 35 2.2k 1.4× 1.5k 1.3× 538 0.6× 607 1.0× 482 1.4× 221 3.7k
Francesco Perrone Italy 38 3.6k 2.2× 1.8k 1.6× 1.1k 1.1× 870 1.5× 468 1.3× 188 5.9k
Francesco Pignatti Netherlands 28 854 0.5× 612 0.5× 479 0.5× 265 0.4× 527 1.5× 102 2.8k
Lynne Penberthy United States 21 1.8k 1.1× 942 0.8× 811 0.8× 838 1.4× 382 1.1× 36 5.3k

Countries citing papers authored by Sean Khozin

Since Specialization
Citations

This map shows the geographic impact of Sean Khozin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Khozin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Khozin more than expected).

Fields of papers citing papers by Sean Khozin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Khozin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Khozin. The network helps show where Sean Khozin may publish in the future.

Co-authorship network of co-authors of Sean Khozin

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Khozin. A scholar is included among the top collaborators of Sean Khozin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Khozin. Sean Khozin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burns, Leah, et al.. (2023). Real-world evidence for regulatory decision-making: updated guidance from around the world. Frontiers in Medicine. 10. 1236462–1236462. 16 indexed citations
2.
Harvey, R. Donald, Suanna S. Bruinooge, Li Chen, et al.. (2021). Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO- Friends Recommendations. Clinical Cancer Research. 27(9). 2430–2434. 29 indexed citations
3.
Atkins, Johnique T., Goldy C. George, Kenneth R. Hess, et al.. (2020). Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials. British Journal of Cancer. 123(10). 1496–1501. 66 indexed citations
4.
5.
Shah, Pratik, Sean Khozin, Ryan Goosen, et al.. (2019). Artificial intelligence and machine learning in clinical development: a translational perspective. npj Digital Medicine. 2(1). 69–69. 294 indexed citations
6.
Khozin, Sean & Andrea Coravos. (2019). Decentralized Trials in the Age of Real‐World Evidence and Inclusivity in Clinical Investigations. Clinical Pharmacology & Therapeutics. 106(1). 25–27. 83 indexed citations
7.
Coravos, Andrea, Sean Khozin, & Kenneth D. Mandl. (2019). Developing and adopting safe and effective digital biomarkers to improve patient outcomes. npj Digital Medicine. 2(1). 194 indexed citations
8.
9.
Guinn, Daphne, et al.. (2018). Assessing function of electronic health records for real-world data generation. BMJ evidence-based medicine. 24(3). 95–98. 11 indexed citations
10.
Bertagnolli, Monica M., Oliver Sartor, Bruce A. Chabner, et al.. (2017). Advantages of a Truly Open-Access Data-Sharing Model. New England Journal of Medicine. 376(12). 1178–1181. 60 indexed citations
11.
Khozin, Sean, et al.. (2016). Evaluating the potential for digital submission of expedited premarket safety reports to the FDA. Nature Reviews Drug Discovery. 15(10). 670–671. 3 indexed citations
12.
Waqar, Saiama N., Philip Bonomi, Ramaswamy Govindan, et al.. (2016). Clinician Perspectives on Current Issues in Lung Cancer Drug Development. Journal of Thoracic Oncology. 11(9). 1387–1396. 8 indexed citations
13.
Jarow, Jonathan P., Sandra J. Casak, Meredith K. Chuk, Lori A. Ehrlich, & Sean Khozin. (2016). The Majority of Expedited Investigational New Drug Safety Reports Are Uninformative. Clinical Cancer Research. 22(9). 2111–2113. 17 indexed citations
14.
Kazandjian, Dickran, Sean Khozin, Gideon M. Blumenthal, et al.. (2015). Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy. JAMA Oncology. 2(1). 118–118. 50 indexed citations
15.
Rajan, Arun, Corey A. Carter, Arlene Berman, et al.. (2014). Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial. The Lancet Oncology. 15(2). 191–200. 99 indexed citations
16.
Thomas, Anish, Esther Mena, Karen Kurdziel, et al.. (2013). 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors. Clinical Cancer Research. 19(6). 1487–1493. 19 indexed citations
17.
Rajan, Arun, Sean Khozin, Anish Thomas, et al.. (2013). The Evaluation of Selumetinib a MEK-Inhibitor with and without the Addition of Erlotinib in KRAS Mutated Non-Small Cell Lung Cancer. Annals of Oncology. 24. i7–i7. 1 indexed citations
18.
Thomas, Anish, Liqiang Xi, Corey A. Carter, et al.. (2013). Concurrent Molecular Alterations in Tumors With Germ Line Epidermal Growth Factor Receptor T790M Mutations. Clinical Lung Cancer. 14(4). 452–456. 19 indexed citations
19.
Yang, Yu-an, Oksana I. Dukhanina, Binwu Tang, et al.. (2002). Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects. Journal of Clinical Investigation. 109(12). 1607–1615. 278 indexed citations
20.
Castonguay, Thomas W., et al.. (2002). The effects of adrenalectomy and aldosterone replacement in transgenic mice expressing antisense RNA to the type 2 glucocorticoid receptor. Physiology & Behavior. 77(2-3). 417–423. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul G. Kluetz Breakdown of academic impact, for papers by Barnett S. Kramer Breakdown of academic impact, for papers by Yingye Zheng Breakdown of academic impact, for papers by Lisa Wang Breakdown of academic impact, for papers by Roman Gulati Breakdown of academic impact, for papers by Mourad Tighiouart Breakdown of academic impact, for papers by Gilberto Lopes Breakdown of academic impact, for papers by Francesco Perrone Breakdown of academic impact, for papers by Francesco Pignatti Breakdown of academic impact, for papers by Lynne Penberthy
Rankless by CCL
2026